Inventor · disambiguated record
Raymond G. Lovey
Also filed as: LOVEY RAYMOND · LOVEY RAYMOND G
37 granted patents·3 pending applications·1,313 citations·filing 1981–2011
98Inventor score
Top patents by PatentIndex Score
40 records- 0197US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0297US4358453A1,2,4-Triazolo[4,3-a]pyridinesSCHERING CORP·Filed 1982·Granted Nov 9, 1982·59 cites·20 claims
- 0396US6911428B2Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jun 28, 2005·124 cites·20 claims
- 0496US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0596US4464372AImidazo[1,2-b]pyridazinesSCHERING CORP·Filed 1982·Granted Aug 7, 1984·44 cites·15 claims
- 0695US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0794US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 0894US5661151ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Aug 26, 1997·69 cites·13 claims
- 0993US6403564B1Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 1999·Granted Jun 11, 2002·122 cites·2 claims
- 1093US6277830B15′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferonSCHERING CORP·Filed 1999·Granted Aug 21, 2001·120 cites·43 claims
- 1192US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 1289USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 1387US5714490ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Feb 3, 1998·37 cites·20 claims
- 1486US4507294AImidazo[1,2-a]pyrazinesSCHERING CORP·Filed 1982·Granted Mar 26, 1985·18 cites·25 claims
- 1583US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 1683US4409226AImidazo[1,5-a]pyridinesSCHERING CORP·Filed 1981·Granted Oct 11, 1983·15 cites·29 claims
- 1780US5693626ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 2, 1997·24 cites·11 claims
- 1879US6924270B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Aug 2, 2005·11 cites·16 claims
- 1979US5403937AProcess for preparing intermediates for the synthesis of antifungal agentsSCHERING CORP·Filed 1993·Granted Apr 4, 1995·21 cites·16 claims
- 2077US7115578B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2004·Granted Oct 3, 2006·8 cites·7 claims
- 2174US6673775B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Jan 6, 2004·4 cites·38 claims
- 2274US5703079ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·16 cites·9 claims
- 2374US4737508A1-aryl-1-(1H-azol-1-ylalkyl)-1,3-dihydroisobenzofurans, related derivatives and pharmaceutical compositions thereof useful as antifungalsSCHERING CORP·Filed 1985·Granted Apr 12, 1988·11 cites·18 claims
- 2471US5925648ATricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferaseSCHERING CORP·Filed 1997·Granted Jul 20, 1999·16 cites·13 claims
- 2570US5710154ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Jan 20, 1998·13 cites·20 claims
- 2668US4358454A1,3,4-Triazolo[1,5-a]pyridinesSCHERING CORP·Filed 1982·Granted Nov 9, 1982·6 cites·17 claims
- 2766US4361567ATreatment of peptic ulcer diseaseSCHERING CORP·Filed 1981·Granted Nov 30, 1982·5 cites·10 claims
- 2865US5883097ASoluble azole antifungal saltSCHERING CORP·Filed 1998·Granted Mar 16, 1999·9 cites·18 claims
- 2959US5346898AAnti-fungal uracil compoundsSCHERING CORP·Filed 1992·Granted Sep 13, 1994·8 cites·8 claims
- 3057US4877801A1-Aryl-1-(1H-azol-1-ylalkyl)-1,3-dihydroisobenzofurans, related derivatives and pharmaceutical compositions thereof useful as antifungalsSCHERING CORP·Filed 1988·Granted Oct 31, 1989·4 cites·1 claims
- 3157US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 3255US5238926AAnti-fungal agentsSCHERING CORP·Filed 1992·Granted Aug 24, 1993·8 cites·8 claims
- 3354US5703236ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·11 cites·4 claims
- 3454US5618793ANikkomycin analogsSCHERING CORP·Filed 1995·Granted Apr 8, 1997·6 cites·8 claims
- 3553US2011117057A1Novel peptides as ns3-serine protease inhibitors of hepatitis c virusSCHERING CORP·Filed 2010·Application pending·0 cites
- 3653US2005059606A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2004·Application pending·0 cites
- 3751US7595299B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2005·Granted Sep 29, 2009·0 cites·5 claims
- 3843US5236900AAnti-fungal agentsSCHERING CORP·Filed 1991·Granted Aug 17, 1993·5 cites·9 claims
- 3942US5461055ANikkomycin analogsSCHERING CORP·Filed 1994·Granted Oct 24, 1995·2 cites·9 claims
- 4032US5698557AHydroxy-substituted antifungalsSCHERING CORP·Filed 1996·Granted Dec 16, 1997·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →